Changes in the vitamin D endocrine system and bone turnover after oral vitamin D3 supplementation in healthy adults: Results of a randomised trial

BMC Endocrine Disorders

Volumn 12, Issue , 2012, Pages

  Holvik, Kristin ^a,b   Madar, Ahmed A ^b   Meyer, Haakon E ^a,b   Lofthus, Cathrine M ^c   Stene, Lars C ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

1,25 dihydroxyvitamin D; 25 hydroxyvitamin D; Bone turnover; Cholecalciferol; Parathyroid hormone; Randomised trial; Supplementation; Tartrate resistant acid phosphatase; Vitamin D3

Indexed keywords

COLECALCIFEROL; FISH OIL; MULTIVITAMIN; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D; VITAPLEX ABCD;

ADULT; AGE; ARTICLE; BODY MASS; BONE METABOLISM; BONE TURNOVER; CLINICAL TRIAL; ETHNICITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OSTEOLYSIS; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 84862225320     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-12-7     Document Type: Article

References (28)

1. Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sørensen OH. Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr 2001, 86(Suppl 1):S97-S103.
2. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008, 87:1080S-1086S.
3. Pedersen JI. Vitamin D requirement and setting recommendation levels - current Nordic view. Nutr Rev 2008, 66:S165-S169.
4. Doets EL, de Wit LS, Dhonukshe-Rutten RA, Cavelaars AE, Raats MM, Timotijevic L, Brzozowska A, Wijnhoven TM, Pavlovic M, Totland TH, Andersen LF, Ruprich J, Pijls LT, Ashwell M, Lambert JP, Veer P, de Groot LC. Current micronutrient recommendations in Europe: towards understanding their differences and similarities. Eur J Nutr 2008, 47(Suppl 1):17-40.
5. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Food and Nutrition Board: Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press, Washington D.C, Committee to Review Dietary Reference Intakes for Vitamin D and Calcium.
6. Nordic Council of Ministers Nordic Nutrition Recommendations 2004, , Copenhagen, Nordic Council of Ministers.
7. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux M. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
8. Viljakainen HT, Väisänen M, Kemi V, Rikkonen T, Kröger H, Laitinen EK, Rita H, Lamberg-Allardt C. Wintertime vitamin D supplementation inhibits seasonal variation of calcitropic hormones and maintains bone turnover in healthy men. J Bone Miner Res 2009, 24:346-352. 10.1359/jbmr.081009, 18847321.
9. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999, 69:842-856.
10. Björkman M, Sorva A, Tilvis R. Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr 2009, 48:160-166. 10.1016/j.archger.2007.12.005, 18243368.
11. Barnes MS, Robson PJ, Bonham MP, Strain JJ, Wallace JM. Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. Eur J Clin Nutr 2006, 60:727-733. 10.1038/sj.ejcn.1602374, 16391584.
12. Seamans KM, Hill TR, Wallace JM, Horigan G, Lucey AJ, Barnes MS, Taylor N, Bonham MP, Muldowney S, Duffy EM, Strain JJ, Kiely M, Cashman KD. Cholecalciferol supplementation throughout winter does not affect markers of bone turnover in healthy young and elderly adults. J Nutr 2010, 140:454-460. 10.3945/jn.109.113480, 20089776.
13. Pignotti GA, Genaro PS, Pinheiro MM, Szejnfeld VL, Martini LA. Is a lower dose of vitamin D supplementation enough to increase 25(OH)D status in a sunny country?. Eur J Nutr 2010, 49:277-283. 10.1007/s00394-009-0084-0, 19946776.
14. Holvik K, Madar AA, Meyer HE, Lofthus CM, Stene LC. A randomised comparison of increase in serum 25-hydroxyvitamin D concentration after 4 weeks of daily oral intake of 10 μg cholecalciferol from multivitamin tablets or fish oil capsules in healthy young adults. Br J Nutr 2007, 98:620-625. 10.1017/S000711450773074X, 17456248.
15. Meyer HE, Holvik K, Lofthus CM, Tennakoon SU. Vitamin D status in Sri Lankans living in Sri Lanka and Norway. Br J Nutr 2008, 99:941-944.
16. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007, 92:2058-2065. 10.1210/jc.2006-1525, 17341569.
17. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22:477-501. 10.1210/er.22.4.477, 11493580.
18. Mejborn H, Brot C, Hansen HB, Koch B, Hyldstrup L, Mortensen L, Mosekilde L, Mølgård C, Petersen T, Rasmussen SE, Rasmussen LB. D-vitaminstatus i den danske befolkning bør forbedres (Vitamin D status in the Danish population should be improved) 2004, Danish Ministry of Food, Agriculture and Fisheries, Copenhagen.
19. Meyer HE, Brunvand L, Brustad M, Holvik K, Johansson L, Paulsen JE. Tiltak for å sikre en god vitamin D-status i befolkningen (Measures to ensure a good vitamin D status in the population) 2006, Norwegian National Nutrition Council, Oslo.
20. Bischoff-Ferrari H. Vitamin D: What is an adequate vitamin D level and how much supplementation is necessary?. Best Pract Res Clin Rheumatol 2009, 23:789-795. 10.1016/j.berh.2009.09.005, 19945690.
21. Henriksen K, Tanko LB, Qvist P, Delmas PD, Christiansen C, Karsdal MA. Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases. Osteoporos Int 2007, 18:681-685. 10.1007/s00198-006-0286-8, 17124552.
22. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, Andon MB, Smith KT, Heaney RP. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994, 93:799-808. 10.1172/JCI117034, 293933, 8113412.
23. Kogawa M, Anderson PH, Findlay DM, Morris HA, Atkins GJ. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol 2010, 121:277-280. 10.1016/j.jsbmb.2010.03.048, 20304055.
24. Anderson PH, Atkins GJ. The skeleton as an intracrine organ for vitamin D metabolism. Mol Aspects Med 2008, 29:397-406. 10.1016/j.mam.2008.05.003, 18602685.
25. Poulsen RC, Moughan PJ, Kruger MC. Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp Biol Med 2007, 232:1275-1288.
26. Salari P, Rezaie A, Larijani B, Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 2008, 14:RA37-RA44.
27. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003, 18:1206-1216. 10.1359/jbmr.2003.18.7.1206, 12854830.
28. Ahmadieh H, Arabi A. Vitamins and bone health: beyond calcium and vitamin D. Nutr Rev 2011, 69:584-598. 10.1111/j.1753-4887.2011.00372.x, 21967159.